急性心肌梗塞溶栓疗法的探讨  

Evaluation of Thrombolytic Therapy in AMI

作　　者：王学忠[1] 齐晓勇[1] 徐力飞[1] 张国志[1] 李继坤[1] 韩玉平[1] 谷剑[1] 

机构地区：[1]河北省医院

出　　处：《天津医药》1991年第3期159-161,共3页Tianjin Medical Journal

摘　　要：本文分析152例急性心肌梗塞应用蝮蛇抗栓酶溶栓疗法作为观察组并与同期采用以往常规疗法治疗100例急性心肌梗塞为对照组。结果表明:前者 ST 段在24小时内回至等电位线者占56%(86/152),时间为36.2±12.2小时,与后者71±13.0小时相比 P<0.01;观察组酶学峰值提前者77例占50%,对照组无提前。对发病超过6小时的病例仍有效,两组疗效比较,观察组总有效率99.9%,对照组87%,二者差异性显著(P<0.01)。值得今后推广使用。Thrombolytic therapy with Agkistrodon Halys(A.Halys)in 152 cases of acutemyocardial infarction and with conventional treatment in 100 cases as control groupwas investigated.It was demonstrated that 56%(86/152)of the patients in Halysgroup the electrocardiographic ST segment recovered normal level within 24 hours,the average time was 36.2±12.2 hours and 71±13 hours in the control group(P<0.01).In 50% of the Halys group,enzymes reached peak levels early than normal.It was also effective to the patients with the time of admission over 6 hours.Theeffective rate was 99.9% in Halys group and 87% in the control group(P<0.01).It was suggested this method was worth continuing in clinical use.

关 键 词：心肌梗塞 溶栓疗法 

分 类 号：R542.220.5[医药卫生—心血管疾病]